Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in diabetic affected population
4.1.2 Increase in obese population
4.2 Restraints
4.2.1 Availability of alternative treatments
4.2.2 High cost of Diabetic Devices
4.3 Opportunities
4.3.1 growing industrialization and urbanization
4.4 Challenges
4.4.1 lack of awareness among people
4.4.2 Rise in the number of oral drugs
Chapter 5 Europe Diabetes Devices Market – By Product
5.1 Glucose Monitoring Devices
5.1.1 Self-Monitoring Blood Glucose meters
5.1.2 Blood Glucose Testing Strips
5.1.3 Lancets
5.1.4 Continuous Glucose Monitoring Devices
5.1.5 Others
5.2 Insulin Delivery Devices
5.2.1 Insulin Syringes
5.2.2 Insulin Pens
5.2.3 Insulin Pumps
5.2.4 Others
5.3 Diabetes Monitoring Software
5.4 Artificial Pancreas System
5.5 Others
Chapter 6 Europe Diabetes Devices Market – By Distribution Channels
6.1 Hospitals Pharmacies
6.2 Retail Pharmacies
6.3 Online Pharmacies
6.4 Diabetic Clinics
6.5 Diabetic Centers
6.6 Others
Chapter 7 Europe Diabetes Devices Market – By End-Users
7.1 Hospitals
7.2 Clinics
7.3 Home Healthcare
7.4 Ambulatory care
7.5 Others
Chapter 8 Europe Diabetes Devices Market - By Geography
8.1 Introduction
8.3 Europe
8.3.1 U.K.
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6. Others
Chapter 9 Europe Diabetes Devices Market - Company Profiles
9.1 Medtronic Public Limited Company
9.2 Novo Nordisk A/S
9.3 Sanofi S.A.
9.4 Eli Lilly and Company
9.5 F. Hoffmann-La Roche Ltd.
9.6 Abbott Laboratories
9.7 Cellnovo
9.8 LifeScan, Inc.
9.9 Owen Mumford Ltd.
9.10 Acon Laboratories
9.11 J&J
9.15Ypsomed AG
Chapter 10 Europe Diabetes Devices Market - Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 11 Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
